Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2025-12-24 @ 10:07 PM
NCT ID:
NCT07194135
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 45 to 75 years
* Radiographically confirmed knee osteoarthritis (Kellgren-Lawrence grade II-III)
* Persistent knee pain for at least 3 months despite oral non-steroidal anti-inflammatory drugs
* Ability to provide informed consent
Exclusion Criteria:
* Prior intra-articular injection within the past 6 months
* Inflammatory arthritis (e.g., rheumatoid arthritis, gout)
* Advanced knee osteoarthritis (Kellgren-Lawrence grade IV)
* Active joint or systemic infection
* Bleeding disorder or anticoagulant use contraindicating injection
* Uncontrolled diabetes mellitus
* Known hypersensitivity to tenoxicam or triamcinolone acetonide
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
75 Years
Study:
NCT07194135
Study Brief:
Protocol Section:
NCT07194135